584 related articles for article (PubMed ID: 11170179)
1. T-cell reactivity to multiple myelin antigens in multiple sclerosis patients and healthy controls.
Hellings N; Barée M; Verhoeven C; D'hooghe MB; Medaer R; Bernard CC; Raus J; Stinissen P
J Neurosci Res; 2001 Feb; 63(3):290-302. PubMed ID: 11170179
[TBL] [Abstract][Full Text] [Related]
2. Induction of circulating myelin basic protein and proteolipid protein-specific transforming growth factor-beta1-secreting Th3 T cells by oral administration of myelin in multiple sclerosis patients.
Fukaura H; Kent SC; Pietrusewicz MJ; Khoury SJ; Weiner HL; Hafler DA
J Clin Invest; 1996 Jul; 98(1):70-7. PubMed ID: 8690806
[TBL] [Abstract][Full Text] [Related]
3. Reactivity to myelin antigens in multiple sclerosis. Peripheral blood lymphocytes respond predominantly to myelin oligodendrocyte glycoprotein.
Kerlero de Rosbo N; Milo R; Lees MB; Burger D; Bernard CC; Ben-Nun A
J Clin Invest; 1993 Dec; 92(6):2602-8. PubMed ID: 7504688
[TBL] [Abstract][Full Text] [Related]
4. Differences between T-cell reactivities to major myelin protein-derived peptides in opticospinal and conventional forms of multiple sclerosis and healthy controls.
Minohara M; Ochi H; Matsushita S; Irie A; Nishimura Y; Kira J
Tissue Antigens; 2001 May; 57(5):447-56. PubMed ID: 11556969
[TBL] [Abstract][Full Text] [Related]
5. Autoreactive T and B cells in nervous system diseases.
Sun JB
Acta Neurol Scand Suppl; 1993; 142():1-56. PubMed ID: 8382894
[TBL] [Abstract][Full Text] [Related]
6. Increased frequency of interleukin 2-responsive T cells specific for myelin basic protein and proteolipid protein in peripheral blood and cerebrospinal fluid of patients with multiple sclerosis.
Zhang J; Markovic-Plese S; Lacet B; Raus J; Weiner HL; Hafler DA
J Exp Med; 1994 Mar; 179(3):973-84. PubMed ID: 7509366
[TBL] [Abstract][Full Text] [Related]
7. Multiple sclerosis patients show sexual dimorphism in cytokine responses to myelin antigens.
Moldovan IR; Cotleur AC; Zamor N; Butler RS; Pelfrey CM
J Neuroimmunol; 2008 Jan; 193(1-2):161-9. PubMed ID: 18022700
[TBL] [Abstract][Full Text] [Related]
8. Reactivity pattern and cytokine profile of T cells primed by myelin peptides in multiple sclerosis and healthy individuals.
Tejada-Simon MV; Hong J; Rivera VM; Zhang JZ
Eur J Immunol; 2001 Mar; 31(3):907-17. PubMed ID: 11241296
[TBL] [Abstract][Full Text] [Related]
9. Longitudinal study of antimyelin T-cell reactivity in relapsing-remitting multiple sclerosis: association with clinical and MRI activity.
Hellings N; Gelin G; Medaer R; Bruckers L; Palmers Y; Raus J; Stinissen P
J Neuroimmunol; 2002 May; 126(1-2):143-60. PubMed ID: 12020966
[TBL] [Abstract][Full Text] [Related]
10. Functional properties of myelin oligodendrocyte glycoprotein-reactive T cells in multiple sclerosis patients and controls.
Van der Aa A; Hellings N; Bernard CC; Raus J; Stinissen P
J Neuroimmunol; 2003 Apr; 137(1-2):164-76. PubMed ID: 12667661
[TBL] [Abstract][Full Text] [Related]
11. Autoreactivity to myelin antigens: myelin/oligodendrocyte glycoprotein is a prevalent autoantigen.
Diaz-Villoslada P; Shih A; Shao L; Genain CP; Hauser SL
J Neuroimmunol; 1999 Sep; 99(1):36-43. PubMed ID: 10496175
[TBL] [Abstract][Full Text] [Related]
12. Chronic relapsing experimental autoimmune encephalomyelitis with a delayed onset and an atypical clinical course, induced in PL/J mice by myelin oligodendrocyte glycoprotein (MOG)-derived peptide: preliminary analysis of MOG T cell epitopes.
Kerlero de Rosbo N; Mendel I; Ben-Nun A
Eur J Immunol; 1995 Apr; 25(4):985-93. PubMed ID: 7737302
[TBL] [Abstract][Full Text] [Related]
13. Predominance of the autoimmune response to myelin oligodendrocyte glycoprotein (MOG) in multiple sclerosis: reactivity to the extracellular domain of MOG is directed against three main regions.
Kerlero de Rosbo N; Hoffman M; Mendel I; Yust I; Kaye J; Bakimer R; Flechter S; Abramsky O; Milo R; Karni A; Ben-Nun A
Eur J Immunol; 1997 Nov; 27(11):3059-69. PubMed ID: 9394837
[TBL] [Abstract][Full Text] [Related]
14. Time course of T-cell responses to MOG and MBP in patients with clinically isolated syndromes.
Correale J; de los Milagros Bassani Molinas M
J Neuroimmunol; 2003 Mar; 136(1-2):162-71. PubMed ID: 12620656
[TBL] [Abstract][Full Text] [Related]
15. Interferon-gamma, interleukin-4 and transforming growth factor-beta mRNA expression in multiple sclerosis and myasthenia gravis.
Link J
Acta Neurol Scand Suppl; 1994; 158():1-58. PubMed ID: 7732782
[TBL] [Abstract][Full Text] [Related]
16. Myelin basic protein and myelin oligodendrocyte glycoprotein T-cell repertoire in childhood and juvenile multiple sclerosis.
Correale J; Tenembaum SN
Mult Scler; 2006 Aug; 12(4):412-20. PubMed ID: 16900754
[TBL] [Abstract][Full Text] [Related]
17. Elispot assay detection of cytokine secretion in multiple sclerosis patients treated with interferon-beta1a or glatiramer acetate compared with untreated patients.
Jansson A; Ernerudh J; Kvarnström M; Ekerfelt C; Vrethem M
Mult Scler; 2003 Oct; 9(5):440-5. PubMed ID: 14582766
[TBL] [Abstract][Full Text] [Related]
18. T cell reactivity to P0, P2, PMP-22, and myelin basic protein in patients with Guillain-Barre syndrome and chronic inflammatory demyelinating polyradiculoneuropathy.
Csurhes PA; Sullivan AA; Green K; Pender MP; McCombe PA
J Neurol Neurosurg Psychiatry; 2005 Oct; 76(10):1431-9. PubMed ID: 16170091
[TBL] [Abstract][Full Text] [Related]
19. Cytokine secretion profile of myelin basic protein-specific T cells in multiple sclerosis.
Rohowsky-Kochan C; Molinaro D; Cook SD
Mult Scler; 2000 Apr; 6(2):69-77. PubMed ID: 10773850
[TBL] [Abstract][Full Text] [Related]
20. Glatiramer acetate-reactive peripheral blood mononuclear cells respond to multiple myelin antigens with a Th2-biased phenotype.
Dhib-Jalbut S; Chen M; Said A; Zhan M; Johnson KP; Martin R
J Neuroimmunol; 2003 Jul; 140(1-2):163-71. PubMed ID: 12864985
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]